ResLit - Antimicrobial Resistance Gene & Mutation Database

Protein ChangeG195D

Validation StatusCandidate

Databases

Reslit

Overview

Resistance To: piperacillin tazobactam|ceftazidime|cefepime|imipenem|meropenem|ciprofloxacin, piperacillin tazobactam|ceftazidime|cefepime|meropenem|imipenem|tobramycin|ciprofloxacin
Organisms: Pseudomonas aeruginosa
Papers: 2

Paper Information2

Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.

Protein Change: G195D
Confers Resistance To: piperacillin tazobactam|ceftazidime|cefepime|imipenem|meropenem|ciprofloxacin
Validation Method: sequencing and phenotypic testing
Source Database: Reslit

Monitoring of Pseudomonas aeruginosa mutational resistome dynamics using an enrichment panel for direct sequencing of clinical samples.

Detected in ST175 isolate.

Protein Change: G195D
Organisms: Pseudomonas aeruginosa
Confers Resistance To: piperacillin tazobactam|ceftazidime|cefepime|meropenem|imipenem|tobramycin|ciprofloxacin
Validation Method: direct sequencing with enrichment panel
Source Database: Reslit

Comments (0)

No comments yet. Be the first to comment!

Browse AMR Mutations